Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
1.720
-0.100 (-5.49%)
At close: Aug 27, 2025, 4:00 PM
1.700
-0.020 (-1.16%)
After-hours: Aug 27, 2025, 7:42 PM EDT
Q32 Bio Stock Forecast
QTTB's stock price has decreased by -95.6% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 7 analysts that cover Q32 Bio stock have a consensus rating of "Hold" and an average price target of $24, which forecasts a 1,295.35% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $95.
Price Target: $24 (+1,295.35%)
Analyst Consensus: Hold
* Price targets were last updated on Mar 12, 2025.
Analyst Ratings
The average analyst rating for Q32 Bio stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +772.09% | Mar 12, 2025 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $22 → $3 | Buy → Hold | Downgrades | $22 → $3 | +74.42% | Feb 11, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $20 → $4 | Buy → Hold | Downgrades | $20 → $4 | +132.56% | Feb 11, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $64 → $22 | Buy | Maintains | $64 → $22 | +1,179.07% | Dec 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 12, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.32
from -6.58
EPS Next Year
-4.47
from -3.32
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.49 | -3.82 | |
| Avg | -3.32 | -4.47 | |
| Low | -4.06 | -5.01 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.